SUBSCRIBE
SUBSCRIBE
News   Business

MannKind Corporation Says No Afresa Partnership In 2009

October 7, 2009 | 
1 min read
Reuters - MannKind Corp (MNKD.O) said it would be unable to conclude a partnership deal for its inhaled insulin product, Afresa, by year-end as it plans to wait for the U.S. health regulator's response on its new drug application for the product.
Alliances
MORE ON THIS TOPIC
Concept of saving money with a pink colored piggy bank held in a hand in front of a blackboard with hand drawn coins
Weight loss
Novo’s CagriSema Falls to Lilly’s Zepbound in Daring Head-to-Head Test
February 23, 2026
 · 
4 min read
 · 
Annalee Armstrong
Illustration of cardboard box filled with office supplies, a computer keyboard, lamp, and a potted plant
Layoff Tracker
BMS, Catalent Further Whittle Workforces
February 23, 2026
 · 
57 min read
 · 
BioSpace Editorial Staff
Insights
Redefining Obesity Treatment Beyond GLP-1 Limits
February 19, 2026
 · 
1 min read
 · 
Jennifer Smith-Parker
Piggy bank rocket launcher with smoke trail on blue background. Savings growth concept. 3D Rendering, 3D Illustration
Alzheimer’s disease
Korsana Joins Alzheimer’s Amyloid Arena With $150M Debut, Next-Gen Antibody
February 18, 2026
 · 
2 min read
 · 
Tristan Manalac